Practical starting points for food, beverage, ingredient, dietary supplement, and specialist testing questions, common references, and project scoping.
Use the selector as reference context only. Technical review determines method-and-matrix fit and the final project scope.
Need pricing or timing information? Submit a quote request.
Each section is focused, so you can jump straight to what you need.
Announcements, regulatory updates, and lab news.
Current as of August 26, 2026: Florida's 7-OH limits, 100:1 mitragynine ratio, labeling rules, federal requirements, and the updated Test Code 814 reporting approach.
Effective August 26, 2026, DEA's temporary order places mitragynine pseudoindoxyl, MGM-15, and MGM-16 in Schedule I through August 26, 2028, subject to possible extension.
Part Number 801 (7-Hydroxymitragynine Relative Alkaloid Ratio) supports reporting against Utah's effective ratio-based 7-OH framework.